| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2575935 | The American Journal of Geriatric Pharmacotherapy | 2009 | 19 Pages |
Abstract
Conclusions: Despite disappointing results from recently completed Phase III trials of several novel compounds, the extent and breadth of activity at all phases of clinical development suggest that new pharmacotherapeutic options for the treatment of AD will become available within the next decade.
Related Topics
Health Sciences
Medicine and Dentistry
Geriatrics and Gerontology
Authors
Marwan N. MD,